Titre : Tests fonctionnels de l'axe hypophysosurrénalien

Tests fonctionnels de l'axe hypophysosurrénalien : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tests fonctionnels de l'axe hypophysosurrénalien : Questions médicales les plus fréquentes", "headline": "Tests fonctionnels de l'axe hypophysosurrénalien : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tests fonctionnels de l'axe hypophysosurrénalien : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-19", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tests fonctionnels de l'axe hypophysosurrénalien" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Techniques de diagnostic endocrinien", "url": "https://questionsmedicales.fr/mesh/D003940", "about": { "@type": "MedicalCondition", "name": "Techniques de diagnostic endocrinien", "code": { "@type": "MedicalCode", "code": "D003940", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E01.370.374" } } }, "about": { "@type": "MedicalCondition", "name": "Tests fonctionnels de l'axe hypophysosurrénalien", "alternateName": "Pituitary-Adrenal Function Tests", "code": { "@type": "MedicalCode", "code": "D010912", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zuleyha Karaca", "url": "https://questionsmedicales.fr/author/Zuleyha%20Karaca", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Fahrettin Kelestimur", "url": "https://questionsmedicales.fr/author/Fahrettin%20Kelestimur", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Meg Keil", "url": "https://questionsmedicales.fr/author/Meg%20Keil", "affiliation": { "@type": "Organization", "name": "Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Christina Tatsi", "url": "https://questionsmedicales.fr/author/Christina%20Tatsi", "affiliation": { "@type": "Organization", "name": "Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Kursad Unluhizarci", "url": "https://questionsmedicales.fr/author/Kursad%20Unluhizarci", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36807581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jafc.2c07264" } }, { "@type": "ScholarlyArticle", "name": "Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na", "datePublished": "2023-06-24", "url": "https://questionsmedicales.fr/article/37354314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s43440-023-00508-x" } }, { "@type": "ScholarlyArticle", "name": "Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37021557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jsfa.12608" } }, { "@type": "ScholarlyArticle", "name": "Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37070956", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.molpharmaceut.2c01117" } }, { "@type": "ScholarlyArticle", "name": "Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36504232", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2em00396a" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Diagnostic", "item": "https://questionsmedicales.fr/mesh/D003933" }, { "@type": "ListItem", "position": 3, "name": "Techniques et procédures diagnostiques", "item": "https://questionsmedicales.fr/mesh/D019937" }, { "@type": "ListItem", "position": 4, "name": "Techniques de diagnostic endocrinien", "item": "https://questionsmedicales.fr/mesh/D003940" }, { "@type": "ListItem", "position": 5, "name": "Tests fonctionnels de l'axe hypophysosurrénalien", "item": "https://questionsmedicales.fr/mesh/D010912" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tests fonctionnels de l'axe hypophysosurrénalien - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tests fonctionnels de l'axe hypophysosurrénalien", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tests fonctionnels de l'axe hypophysosurrénalien", "description": "Quels tests évaluent l'axe hypophysosurrénalien ?\nComment interpréter un taux élevé de cortisol ?\nQuel est le rôle du test de stimulation à l'ACTH ?\nQuand réaliser un test de suppression à la dexaméthasone ?\nQuels symptômes justifient ces tests ?", "url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tests fonctionnels de l'axe hypophysosurrénalien", "description": "Quels symptômes indiquent un dysfonctionnement surrénalien ?\nComment reconnaître le syndrome de Cushing ?\nQuels signes d'insuffisance surrénalienne ?\nQuels symptômes d'un excès de cortisol ?\nQuels symptômes d'un déficit en cortisol ?", "url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tests fonctionnels de l'axe hypophysosurrénalien", "description": "Peut-on prévenir les troubles surrénaliens ?\nComment réduire le stress pour protéger les surrénales ?\nL'alimentation influence-t-elle la santé surrénalienne ?\nQuels examens préventifs sont recommandés ?\nComment éviter les médicaments à risque pour les surrénales ?", "url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tests fonctionnels de l'axe hypophysosurrénalien", "description": "Comment traiter le syndrome de Cushing ?\nQuel traitement pour l'insuffisance surrénalienne ?\nQuels médicaments pour réguler le cortisol ?\nComment gérer les effets secondaires des traitements ?\nY a-t-il des traitements naturels pour ces troubles ?", "url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tests fonctionnels de l'axe hypophysosurrénalien", "description": "Quelles complications peuvent survenir avec le syndrome de Cushing ?\nQuels risques d'une insuffisance surrénalienne non traitée ?\nComment les troubles surrénaliens affectent-ils la santé mentale ?\nQuelles complications liées aux traitements hormonaux ?\nQuels impacts sur la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tests fonctionnels de l'axe hypophysosurrénalien", "description": "Quels facteurs augmentent le risque de syndrome de Cushing ?\nY a-t-il des prédispositions génétiques ?\nComment le stress influence-t-il les troubles surrénaliens ?\nQuels antécédents médicaux sont des facteurs de risque ?\nL'alimentation joue-t-elle un rôle dans ces troubles ?", "url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels tests évaluent l'axe hypophysosurrénalien ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de stimulation à l'ACTH et le test de suppression à la dexaméthasone sont courants." } }, { "@type": "Question", "name": "Comment interpréter un taux élevé de cortisol ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un taux élevé peut indiquer un syndrome de Cushing ou une hyperplasie surrénalienne." } }, { "@type": "Question", "name": "Quel est le rôle du test de stimulation à l'ACTH ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Il évalue la capacité des glandes surrénales à produire du cortisol en réponse à l'ACTH." } }, { "@type": "Question", "name": "Quand réaliser un test de suppression à la dexaméthasone ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il est effectué pour diagnostiquer le syndrome de Cushing en vérifiant la réponse au cortisol." } }, { "@type": "Question", "name": "Quels symptômes justifient ces tests ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme fatigue, prise de poids ou hypertension peuvent nécessiter ces tests." } }, { "@type": "Question", "name": "Quels symptômes indiquent un dysfonctionnement surrénalien ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, perte de poids, hypotension et troubles de l'humeur sont des signes fréquents." } }, { "@type": "Question", "name": "Comment reconnaître le syndrome de Cushing ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Obésité centrale, vergetures, et hypertension artérielle sont des indicateurs clés." } }, { "@type": "Question", "name": "Quels signes d'insuffisance surrénalienne ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent fatigue extrême, hypotension, et hyperpigmentation de la peau." } }, { "@type": "Question", "name": "Quels symptômes d'un excès de cortisol ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent prise de poids, acné, et irrégularités menstruelles chez les femmes." } }, { "@type": "Question", "name": "Quels symptômes d'un déficit en cortisol ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure faiblesse musculaire, nausées et perte d'appétit." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles surrénaliens ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une détection précoce et un suivi médical régulier peuvent aider à prévenir des complications." } }, { "@type": "Question", "name": "Comment réduire le stress pour protéger les surrénales ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la méditation, le yoga et l'exercice régulier peuvent être bénéfiques." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle la santé surrénalienne ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments et faible en sucre peut soutenir la santé surrénalienne." } }, { "@type": "Question", "name": "Quels examens préventifs sont recommandés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des bilans hormonaux réguliers peuvent aider à détecter des anomalies précocement." } }, { "@type": "Question", "name": "Comment éviter les médicaments à risque pour les surrénales ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les corticostéroïdes non prescrits et consultez toujours un médecin avant tout traitement." } }, { "@type": "Question", "name": "Comment traiter le syndrome de Cushing ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure la chirurgie, la radiothérapie ou des médicaments pour réduire le cortisol." } }, { "@type": "Question", "name": "Quel traitement pour l'insuffisance surrénalienne ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est le remplacement hormonal avec des corticostéroïdes." } }, { "@type": "Question", "name": "Quels médicaments pour réguler le cortisol ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme le kétoconazole ou la mitotane peuvent être prescrits." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de surveiller régulièrement les effets secondaires et d'ajuster les doses." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour ces troubles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches comme la gestion du stress et une alimentation équilibrée peuvent aider." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le syndrome de Cushing ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le diabète, l'hypertension et les maladies cardiovasculaires." } }, { "@type": "Question", "name": "Quels risques d'une insuffisance surrénalienne non traitée ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner une crise surrénalienne, potentiellement mortelle sans traitement." } }, { "@type": "Question", "name": "Comment les troubles surrénaliens affectent-ils la santé mentale ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des troubles de l'humeur, de l'anxiété et des dépressions." } }, { "@type": "Question", "name": "Quelles complications liées aux traitements hormonaux ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent entraîner des effets secondaires comme l'ostéoporose et le diabète." } }, { "@type": "Question", "name": "Quels impacts sur la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les troubles surrénaliens peuvent affecter l'énergie, l'humeur et les activités quotidiennes." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de syndrome de Cushing ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le stress chronique et certains médicaments comme les corticostéroïdes sont des facteurs de risque." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Certaines conditions génétiques, comme le syndrome de Cushing familial, augmentent le risque." } }, { "@type": "Question", "name": "Comment le stress influence-t-il les troubles surrénaliens ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut perturber la production hormonale et aggraver les troubles surrénaliens." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont des facteurs de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de maladies endocriniennes ou de traitements hormonaux augmentent le risque." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans ces troubles ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation déséquilibrée peut contribuer à des troubles hormonaux et à l'obésité." } } ] } ] }

Sources (10000 au total)

Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.

Plant bacterial illnesses are common and cause dramatic damage to agricultural goods all over the world, yet there are few efficient bactericides to alleviate them at present. To discover novel antiba...

Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na

Quantitative structure-activity relationship (QSAR) modeling is a method of characterizing the relationship between chemical structures and biological activity. Automated machine learning enables comp... The chemical structures and inhibitory activities of 215 CS derivatives were obtained from the scientific literature. Predictive QSAR models were constructed using molecular descriptors, fingerprints,... The best predictive QSAR models were selected based on the LogLoss value. Using these models, the Matthews correlation coefficient, F1 score, and area under the curve of the test dataset were 0.6729, ... The automated machine learning-based QSAR method developed here should be applicable for the time-efficient construction of predictive models using only a small number of compounds....

Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.

Mesotrione is a triketone widely used as an inhibitor of the hydroxyphenylpyruvate deoxygenase (HPPD) enzyme. However, new agrochemicals should be developed continuously to tackle the problem of herbi... The MIA-QSAR models based on van der Waals radii (r... Multivariate image analysis descriptors corroborated by docking studies were capable of modeling the herbicidal activities of 68 triketones reliably. Due to the substituent effects at the triketone fr...

Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.

Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharm...

Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.

Organic compounds are capable of generating hydroxyl radicals (˙OH) through their excited triplet states in natural water. It is of significance to reveal the underlying mechanism of the generation an...

In vitro and Quantitative and Structure Activity Relationship (QSAR) evaluation of the antifungal activity of terpenoid constituents of essential oils against Alternaria alternata and Fusarium oxysporum

Fungal genera Alternaria and Fusarium include human and plant pathogenic species. Several antifungals have been used for their control, but excessive use has contributed to resistance development in p... To evaluate in vitro and in silico the antifungal activities of terpenoids against Alternaria alternata and Fusarium oxysporum.... The minimum inhibitory concentration and minimum fungicidal concentration values of 27 constituents of essential oils used against Alternaria alternata and Fusarium oxysporum were evaluated in vitro. ... The evaluated compounds proved to be effective antifungals. Thymol was the most active with a minimum inhibitory concentration of 91.6 ± 28.8 μg/ml for A. alternata and F. oxysporum. Quantitative stru... Terpenoids exhibit relevant antifungal activities that should be incorporated into the study of medicinal chemistry. Inclusion of in silico assays in the in vitro evaluation is a valuable tool in the ...

Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors.

3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative ...

Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.

The leading cause of atherosclerotic cardiovascular disease (ASCVD) is elevated low-density lipoprotein cholesterol (LDL-C). Proprotein convertase subtilisin/kexin type 9 (PCSK9) attaches to the domai...

An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands.

A positron emission tomography (PET) radioligand for imaging phosphodiesterase 4D (PDE4D) would benefit drug discovery and the investigation of neuropsychiatric disorders. The most promising radioliga...